Using AI to spot lung scarring on CT scans
Part of Lungs & breathing clinical trials.
This study tests whether an AI tool can correctly find lung scarring (pulmonary fibrosis) on CT scans as well as doctors do. The results could lead to faster, more consistent detection of this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 20 or older
- Had a chest CT scan at Taichung Veterans General Hospital between 2020 and 2024
- Your CT images and radiology report are available for review
- No heart implants, severe pneumonia, or other issues that would make the scan hard to read
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a computer program can reliably measure the amount of lung scarring on chest CT scans. It's for people with certain types of interstitial lung disease who are already scheduled for a routine CT scan.
This study uses a single lung scan to find early signs of progressive scarring (fibrosis) in people with pulmonary fibrosis. It may help doctors predict which patients will get worse faster.
This early (Phase 1) study compares two types of PET-CT scans to see how well they detect and measure lung scarring (pulmonary fibrosis). It may help doctors choose the best scan test for diagnosis in the future.
This study uses an AI computer program to help doctors read low-dose CT scans of the chest to find lung cancer early. It is for people at higher risk due to family history, smoking, or general health check-ups.
This study checks if artificial intelligence (AI) can accurately read CT scans of lung nodules (spots on the lung) to tell if they are cancer. Your participation helps improve diagnosis and may lead to better care.
This study tests whether an AI tool can help doctors read chest CT scans more accurately across the entire lung cancer care process. If you are a doctor who reads chest CT scans, you may be able to join and help improve cancer detection.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.